These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 24315318)

  • 1. Complete prekallikrein deficiency masquerading as a lupus anticoagulant.
    Moore GW; Sangle SR; Archer RA; Maloney JC; Rahman A; D'Cruz DP
    Thromb Res; 2014 Feb; 133(2):301-2. PubMed ID: 24315318
    [No Abstract]   [Full Text] [Related]  

  • 2. Portal and pulmonary hypertension in a case of systematic lupus erythematosus: possible relationship with a clotting abnormality.
    Mackworth-Young CG; Gharavi AE; Boey ML; Hughes GR
    Eur J Rheumatol Inflamm; 1984; 7(3):71-4. PubMed ID: 6443758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the minimally prolonged APTT: Passovoy factor or lupus anticoagulant?
    Triplett DA
    J Pediatr Hematol Oncol; 1996 Aug; 18(3):247-8. PubMed ID: 8689334
    [No Abstract]   [Full Text] [Related]  

  • 4. [Lupus anticoagulant: an old phenomenon in a new perspective].
    Derksen RH; Kater L
    Ned Tijdschr Geneeskd; 1986 May; 130(19):849-51. PubMed ID: 3086756
    [No Abstract]   [Full Text] [Related]  

  • 5. [The evaluation of hemostatic disorders in patients with systemic lupus erythematosus].
    Arshinov AV; Lapin VA; Raĭt IuA
    Ter Arkh; 1999; 71(5):38-40. PubMed ID: 10399229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Activated Seven Lupus Anticoagulant (ASLA) test has comparable sensitivity to classical assays for screening of lupus anticoagulant.
    Marinuzzo M; Adamczuk Y; Varela ML; Pombo G; Forastiero R
    Thromb Haemost; 2005 May; 93(5):1007-9. PubMed ID: 15900652
    [No Abstract]   [Full Text] [Related]  

  • 7. Thromboelastography assessment of coagulation status in parturients with lupus anticoagulant receiving heparin therapy.
    Harnett M; Kodali BS
    Int J Obstet Anesth; 2006 Apr; 15(2):177-8. PubMed ID: 16488131
    [No Abstract]   [Full Text] [Related]  

  • 8. [Multiple cerebral infarcts in a young man].
    Daumerie C; Lefebvre C; Coche E
    Acta Neurol Belg; 1990; 90(3):157-65. PubMed ID: 2120905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cerebral infarct in a patient with systemic lupus erythematosus. The presence of lupus anticoagulant and Libman-Sacks endocarditis].
    Labarga Echeverría P; Antón Botella F; Pinilla Moraza J; Milazo Estefanía A
    Med Clin (Barc); 1992 Jun; 99(2):75. PubMed ID: 1630185
    [No Abstract]   [Full Text] [Related]  

  • 10. Surgery in patients with circulating lupus anticoagulant.
    Shaulian E; Shoenfeld Y; Berliner S; Shaklai M; Pinkhas J
    Int Surg; 1981; 66(2):157-9. PubMed ID: 6792105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of lupus anticoagulant-hypoprothrombinemia syndrome associated with systemic lupus erythematosus.
    Abdo L; Mekinian A; Riviere S; Fain O
    Joint Bone Spine; 2016 Oct; 83(5):589-90. PubMed ID: 26654379
    [No Abstract]   [Full Text] [Related]  

  • 12. [Lupus anticoagulant (LA)].
    Gohchi K
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():694-6. PubMed ID: 15658426
    [No Abstract]   [Full Text] [Related]  

  • 13. Prolonged activated partial thromboplastin time due to plasma prekallikrein deficiency: a case study and literature review on its clinical significance.
    Zhou K; Mehedint D; Khadim H
    Blood Coagul Fibrinolysis; 2019 Sep; 30(6):300-303. PubMed ID: 31318719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Similar mechanism of various lupus anticoagulants.
    Exner T
    Thromb Haemost; 1985 Feb; 53(1):15-8. PubMed ID: 3922078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Presentation of 20 cases of lupus anticoagulant. Proposal for a methodology for its study].
    Mompel Sanjuán A; Abad Gosalbez A; García Pérez A; Marco Vera P
    Sangre (Barc); 1988 Aug; 33(4):306-9. PubMed ID: 3142061
    [No Abstract]   [Full Text] [Related]  

  • 16. [Lupus anticoagulant as a risk factor of thrombosis].
    Lewandowski K; Zawilska K
    Pol Tyg Lek; 1992 Feb 3-10; 47(5-6):154-5. PubMed ID: 1437806
    [No Abstract]   [Full Text] [Related]  

  • 17. Development of consensus guidelines for anticardiolipin and lupus anticoagulant testing.
    Wong RC; Adelstein S; Gillis D; Favaloro EJ
    Semin Thromb Hemost; 2005 Feb; 31(1):39-48. PubMed ID: 15706474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lupus anticoagulants.
    Shapiro SS; Thiagarajan P
    Prog Hemost Thromb; 1982; 6():263-85. PubMed ID: 6820164
    [No Abstract]   [Full Text] [Related]  

  • 19. Mixing studies for abnormal coagulation screen - the current trend.
    Mohammad E; Thachil J
    Clin Chem Lab Med; 2017 Mar; 55(3):e54-e55. PubMed ID: 27522100
    [No Abstract]   [Full Text] [Related]  

  • 20. Challenging hemostasis scenarios in pediatric patients--two case studies.
    Moser KA; Puetz J
    Int J Lab Hematol; 2015 May; 37 Suppl 1():72-7. PubMed ID: 25976963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.